Yiming Ma
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Gut microbiota and health
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 9
- Extracellular vesicles in disease 9
- Circular RNAs in diseases 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 19
- Ferroptosis and cancer prognosis 10
- Respiratory Support and Mechanisms 8
- Co-authors
- Hongying Wang (30 shared papers)Xinhua Zhao (15 shared papers)Sharmila Shankar (11 shared papers)Rohit Srivastava (11 shared papers)Wei Yu (9 shared papers)Xiangming Liu (11 shared papers)Yan Chen (24 shared papers)Zihang Zeng (11 shared papers)
- Journals
- Frontiers in Pharmacology (6 papers)Journal of Cellular and Molecular Medicine (5 papers)Agronomy (4 papers)Frontiers in Oncology (4 papers)Free Radical Biology and Medicine (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yiming Ma
152 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 149
- Cancer Research 630
- Molecular Biology 1.5k
- Oncology 487
- Pulmonary and Respiratory Medicine 519
- Immunology 290
Countries citing papers authored by Yiming Ma
This map shows the geographic impact of Yiming Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Ma more than expected).
Fields of papers citing papers by Yiming Ma
This network shows the impact of papers produced by Yiming Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Ma. The network helps show where Yiming Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiming Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 149 | |
| 2 | 2020 | 138 | |
| 3 | 2018 | 117 | |
| 4 | How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy. | 2019 | 117 |
| 5 | 2021 | 85 | |
| 6 | 2018 | 85 | |
| 7 | 2013 | 82 | |
| 8 | 2012 | 81 | |
| 9 | 2019 | 72 | |
| 10 | 2012 | 62 | |
| 11 | 2017 | 61 | |
| 12 | 2015 | 60 | |
| 13 | 2016 | 55 | |
| 14 | 2011 | 54 | |
| 15 | 2021 | 51 | |
| 16 | 2014 | 48 | |
| 17 | 2010 | 46 | |
| 18 | 2021 | 45 | |
| 19 | 2013 | 44 | |
| 20 | 2017 | 44 |
About Yiming Ma
Yiming Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Epidemiology, having authored 165 papers that have together received 2.9k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), MicroRNA in disease regulation (12 papers), Ferroptosis and cancer prognosis (10 papers), Cancer-related molecular mechanisms research (10 papers), Epigenetics and DNA Methylation (9 papers), Extracellular vesicles in disease (9 papers), Respiratory Support and Mechanisms (8 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Cancer Research (630 citations), Molecular Biology (1.5k citations), Oncology (487 citations), Pulmonary and Respiratory Medicine (519 citations) and Immunology (290 citations). Yiming Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongying Wang, Xinhua Zhao, Sharmila Shankar, Rohit Srivastava, Wei Yu, Xiangming Liu, Yan Chen, Zihang Zeng, Weiwei Li and Jingnan Li. Their work appears in journals such as Frontiers in Pharmacology, Journal of Cellular and Molecular Medicine, Agronomy, Frontiers in Oncology and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.